Express Healthcare
Home  »  News  »  Gurugram’s COVID only facility opens up in Manesar

Gurugram’s COVID only facility opens up in Manesar

0 527
Read Article

The hospital has approximately 150 beds including 24 critical care beds

In order to deal with rising COVID-19 cases in Gurugram, a new COVID only facility has opened up in Manesar, Gurugram. This has happened as a coming together of Medanta – The Medicity, Fortis, Artemis and Medeor. 

The facility was opened to the public today by VS Kundu, Additional Chief Secretary, Haryana and CEO, Gurugram Metropolitan Development Authority (GMDA) along with Ashok Sangwan, Commissioner, Gurugram, Vinay Pratap Singh, MCG Commissioner, Gurugram and Amit Khatri, IAS, Deputy Commissioner, Gurugram.

The hospital has approximately 150 beds including 24 critical care beds. The hospital will only be serving confirmed COVID-19 patients from Gurugram district for which a valid COVID-19 test certificate will be required to get admission to the hospital.

The facility has invested in infrastructure upgrades including superior infection control system, negative pressure ICU rooms, and isolation rooms with HEPA filter exhausts. Senior medical personnel from Medanta, Fortis and Artemis will be staffed to look after patients.

The Hospital is being funded through a collaboration between partner hospital groups, private sector companies in Gurugram, civil society and NGOs such as I Am Gurgaon. A group of private sector CEOs have come together to provide funding support to the hospital, which will tend to patients from all walks of life.

Key people who have led the initiative include Dr Naresh Trehan, Chairman & MD, Medanta, Dr Ashutosh Raghuvanshi, CEO, Fortis Healthcare, Dr Devlina Chakravarty, COO Artemis Hospital, Shamsheer Vayalil, Chairman & MD, VPS Healthcare Group, Gautam Kumra, MD McKinsey & Co, Pramod Bhasin, Co-Founder, Asha Impact, Puneet Bhatia, MD TPG, Sumant Sinha, Chairman & MD, Renew Power, Latika Thukral, Co-Founder I Am Gurgaon and  Deep Kalra, Founder & Chairman Make My Trip.


Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
Are you looking for ICP-MS which can increase productivity and remove time trap from your analysis?
Know More